跳至主要内容
临床试验/CTRI/2022/01/039220
CTRI/2022/01/039220尚未招募2 期

Efficacy of Agnikarma with Apamarga Ksharjalpoorana and Apamarga Ksharsootra application in the management of Bhagandara(Fistula-in-ano)- An open labelled Randomized comparative clinical trail

Institute of teaching and research in Ayurveda Jamnagar Gujarat1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2022年5月2日最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
30
试验地点
1
主要终点
To reduce the reccurrence rate of the Fistula-in-ano

研究概览

简要总结

Fistula-in-Ano is a common anorectal condition in the populations worldwide and its prevalence is second highest after haemorrhoids. Bhagandara (Fistula-in-Ano) is said callous to be cured and considered under the Ashta Maharogas (Eight grave disorders). Kshara is one of the chief drug in the preparation of Kshar-sootra which is gaining worldwide acceptance today. Present study will be carried out to check the efficacy of Apamarga Ksharjalapooran in Fistula-in-Ano.

Ø  Materials and Methods: In the present study total 30 clinically diagnosed patients having sign and symptoms of Bhagandara (Pidika, Srava, Vedana and Kandu in Gudapradesha*)* will be divided in two groups by computer generated randomization. One group of the patients will be treated with Agnikarma with Apamarga Ksharjalpooran and second group of the patients will be treated with Apamarga Kshar-sootra application.

Ø Results and Discussion: Data generated during the above study will be present in a systemic manner as shall be analyzed and the section where the important points of the Conceptual study, Analytical study, Pharmacological study will be discussed.

Ø Follow up: After completion of therapy, follow up will be done for 2 months to assess the status of patient, where patient will be asked to report.

Ø Side Effects: These drugs have no known unwanted effects. It is possible that it may also cause some problems that we are not aware of. Adverse Drug Reaction if any observed will be reported to the Pharmacovigilance cell of I.T.R.A., Jamnagar.

研究设计

研究类型
Interventional
分配方式
Computer generated randomization
盲法
Not Applicable

入排标准

年龄范围
18.00 Year(s) 至 70.00 Year(s)(—)
性别
All

入选标准

  • Patients having sign and symptoms of Bhagandara like Pidika, Srava, Vedana, Kandu Diagnosed cases of low anal single tract Inter-Sphincteric and Trans-Sphincteric Fistula-in-ano Medically fit for surgery irrespective of sex, caste, religion and occupation.

排除标准

  • Patients below 18 years of age and above 70 years of age Fistula-in-Ano with multiple tracks Fistula-in-Ano associated with Piles and Fissure Crohn’s disease Patient with Diabetes Mellitus : FBS: >140 mg/dl, PPBS: >180mg/dl Patient with Hypertension : Systolic BP:>140mmHg, Diastolic BP: >90 mmHg Cardiovascular disease Pregnancy Malignancy Rectal prolapse Hepatitis B, Tuberculosis, HIV, HCV& VDRL positive cases.

结局指标

主要结局

To reduce the reccurrence rate of the Fistula-in-ano

时间窗: upto complete tract healing

To minimize the post operative pain

时间窗: upto complete tract healing

To minimize the duration of treatment

时间窗: upto complete tract healing

次要结局

  • improve quality of life of person(upto complete tract healing)

研究者

发起方
Institute of teaching and research in Ayurveda Jamnagar Gujarat
申办方类型
Research institution and hospital

研究点 (1)

Loading locations...

相似试验